Nanomaterial applications for neurological diseases and central nervous system injury.
The effectiveness of noninvasive treatment for neurological disease is generally limited by the poor entry of therapeutic agents into the central nervous system (CNS). Most CNS drugs cannot permeate into the brain parenchyma because of the blood-brain barrier thus, overcoming this problem has become one of the most significant challenges in the development of neurological therapeutics. Nanotechnology has emerged as an innovative alternative for treating neurological diseases. In fact, rapid advances in nanotechnology have provided promising solutions to this challenge. This review highlights the applications of nanomaterials in the developing neurological field and discusses the evidence for their efficacies.
['Huang|Lijie|L|', 'Hu|Jiangnan|J|', 'Huang|Shengwei|S|', 'Wang|Brian|B|', 'Siaw-Debrah|Felix|F|', 'Nyanzu|Mark|M|', 'Zhang|Yu|Y|', 'Zhuge|Qichuan|Q|']
D000818:Animals D002491:Central Nervous System Agents D016503:Drug Delivery Systems D006801:Humans D049329:Nanostructures D009422:Nervous System Diseases
Nanomaterials Neurological diseases Central nervous system Blood brain barrier